Flow Announces a US$3,000,000 Investment in the Pyure Company Providing Air and Surface Sanitation Solutions
Summary
The company’s flagship product is FDA registered as a class II medical device and PYURE is completing testing on SARS-CoV-2, the virus that causes CoVID-19. PYURE offers portable devices, in-duct units and HVAC integrated solutions that can scale to meet the needs of any user, from individual offices and classrooms to entire buildings. “The PYURE leadership team has combined proven technology and over 15 years of manufacturing expertise to deliver solutions to one of the most pressing challenges of the ongoing pandemic – safe and effective pathogen protection in indoor environments. PYURE’s proprietary technology mimics the way sunlight sanitizes the outdoor environment by safely generating and diffusing hydroxyls and organic oxidants indoors. All subsequent written and oral forward- looking information and statements attributable to the Company or persons acting on its behalf is expressly qualified in its entirety by this notice.